Table 1. Clinical summary for cancer samples.

Cancer type	Mean Age (years)	Standard Deviation (Age in years)	Number of Female: Male	Total Number of Samples	% of Samples in Training	Pathological Stage (if known)
Prostate	67.6	7.5	0:809	809	40%
Ovarian	56.9	11.5	320:0	320	70%
Bladder	67.8	10.7	109:283	392	70%	313 with high pathological grade and 77 low pathological grade
Hepatocellular Carcinoma	67.6	9.2	77:268	345	70%	270 child-pugh A, 34 child-pugh B
Breast	55.9	11	155:0	155	80%
Colorectal	65.7	11	130:75	205	80%
Sarcoma	53.0	17.6	133:72	205	80%
Pancreatic	63.5	10.0	130:75	205	80%
Gastric	66.7	10.0	124:81	205	80%
Lung	63.8	8.4	126:27	153	80%
Esophageal	67.3	8.2	119:86	178	80%
Glioma	52.6	18.6	21:69	90	80%
Biliary	67.7	9.4	12:78	90	80%

The pathological stage and grade of many samples were unknown. Many of the patients’ age from which the sample was obtained were unknown. Only 90 samples from sarcomas, colorectal, esophageal, pancreatic, and gastric cancers were used to calculate the mean and standard deviation of age. Only 40 samples from lung and breast cancer were used to calculate mean and standard deviation of age.